2Verdecchia A,Francisci S,Brenner H,et al.Recent cancer survival in Europe:a 2000-02 period analysis of EUROCARE-4data[J].Lancet Oncol,2007,8(1):784-796.
3Bui JD,Schreiber RD.Immunoediting and inflammation:independent or interdependent processes curropin immunol[J].Cancer Immuno Surveillance,2007,19(2):203-208.
5Crozier JE,McKee RF,Mcardle CS,et al.The presence of a systemic inflmmatory response predicts poorer survival in patients receiving adjuvant 5-Fu chemotherapy following potentially curative resection for colorectal cancer[J].Br J Cancer,2006,94(2):1833-1836.
6Mantovani A,Marchesi F,Porta C,et al.Inflammation and cancer:breast cancer as a prototype[J].Breast,2007,16(2):27-33.
7Li QQ,Lu ZH,Yang L,et al.Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy[J].Asian Pac J Cancer Prev,2014,15(2):945-950.
8Tomohiro A,Takao H,Minoru H,et al.The modifid glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer[J].Surg Today,2014,7(3):835-840.
9Gunter MJ,Stolzenberg SR,Cross AJ,et al.A prospective study of serum C-reactive protein and colorectal cancer risk in men[J].Cancer Res,2006,66(1):2483-2487.
10Longo WE,Virgo KS,Johnson FE,et al.Risk factors for morbidity and mortality after colectomy for colon cancer[J].Dis Colon Rectum,2000,43(1):83-91.
